MDT Stock Overview
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Medtronic plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$79.99 |
| 52 Week High | US$92.02 |
| 52 Week Low | US$68.84 |
| Beta | 0.72 |
| 1 Month Change | 10.24% |
| 3 Month Change | -2.61% |
| 1 Year Change | 0.46% |
| 3 Year Change | -29.74% |
| 5 Year Change | -15.12% |
| Change since IPO | 3,807.91% |
Recent News & Updates
3.5% Yield And Over 15% Annual Return Potential - I Really Like Medtronic
Nov 28Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes
Nov 19
Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings
Nov 17Medtronic Faces Potential Decline Despite Financial Strength
Oct 29Recent updates
3.5% Yield And Over 15% Annual Return Potential - I Really Like Medtronic
Nov 28Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes
Nov 19Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings
Nov 17Medtronic Faces Potential Decline Despite Financial Strength
Oct 29An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued
Oct 19Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly
Oct 04Medtronic: Improved Guidance, Historically Cheap P/E, Yield Reaches 3.5%
Sep 27Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69
Sep 18Medtronic: The Tide Is Turning
Aug 24Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69
Aug 21Medtronic: Dark Clouds Are Clearing - Outperformance Ahead
Aug 14Return Trends At Medtronic (NYSE:MDT) Aren't Appealing
Aug 11Medtronic: Expanding Product Portfolio Without Affecting Dividend Growth
Jul 15Are Medtronic plc (NYSE:MDT) Investors Paying Above The Intrinsic Value?
Jul 09Is Medtronic (NYSE:MDT) A Risky Investment?
Jun 21Medtronic: Weak Forecasts Spoiled Strong Results For The Reporting Quarter
Jun 21Is Medtronic's Dividend In A Good Place?
Jun 14Medtronic (NYSE:MDT) Is Increasing Its Dividend To $0.69
Jun 03Medtronic: Solid Q4 Earnings, Don't Fret About Guidance
May 26Investors Met With Slowing Returns on Capital At Medtronic (NYSE:MDT)
May 04Does This Valuation Of Medtronic plc (NYSE:MDT) Imply Investors Are Overpaying?
Mar 10Where Will Medtronic Stock Be In 4 Years?
Feb 17Medtronic: A Trend Change May Be Underway Ahead Of Earnings
Feb 06Medtronic recalls ~23K Mahurkar hemodialysis catheters
Jan 30These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well
Jan 24Medtronic: Destruction Is Nearly Over
Jan 06Returns At Medtronic (NYSE:MDT) Appear To Be Weighed Down
Dec 28Medtronic: Buy The Dip And Start The DRIP
Dec 07We Discuss Why Medtronic plc's (NYSE:MDT) CEO Compensation May Be Closely Reviewed
Dec 02Medtronic cut to hold at Deutsche Bank on macro headwinds
Nov 16Shareholder Returns
| MDT | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 1.3% | 1.0% | 1.1% |
| 1Y | 0.5% | -2.3% | 11.7% |
Return vs Industry: MDT exceeded the US Medical Equipment industry which returned -2.3% over the past year.
Return vs Market: MDT underperformed the US Market which returned 11.7% over the past year.
Price Volatility
| MDT volatility | |
|---|---|
| MDT Average Weekly Movement | 2.9% |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: MDT is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: MDT's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1949 | 95,000 | Geoff Martha | https://www.medtronic.com |
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products.
Medtronic plc Fundamentals Summary
| MDT fundamental statistics | |
|---|---|
| Market Cap | US$106.36b |
| Earnings (TTM) | US$4.10b |
| Revenue (TTM) | US$31.96b |
25.9x
P/E Ratio3.3x
P/S RatioIs MDT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDT income statement (TTM) | |
|---|---|
| Revenue | US$31.96b |
| Cost of Revenue | US$10.97b |
| Gross Profit | US$20.99b |
| Other Expenses | US$16.88b |
| Earnings | US$4.10b |
Last Reported Earnings
Oct 27, 2023
Next Earnings Date
Feb 20, 2024
| Earnings per share (EPS) | 3.09 |
| Gross Margin | 65.67% |
| Net Profit Margin | 12.84% |
| Debt/Equity Ratio | 48.5% |
How did MDT perform over the long term?
See historical performance and comparison